Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI.
Franzini M, Prontera C, Masotti S, Zucchelli G, Storti S, Passino C, Clerico A
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to compare hepariniated plasma versus serum cTnI levels and to compare cTnI measurements between three different platforms using specimens from healthy individuals and patients with cardiac disease, including those with acute myocardial infarction. The authors state that a portion of the plasma was stored at -80 degrees C before analysis, but a direct comparison between frozen and fresh plasma was not performed.
Summary of Findings
A very close, linear relationship was found between cTnI levels in serum and heparinated plasma when measured by the Tosoh AIA-2000 platform (R=0.999). Compared to cTnI measurements made by the Beckman Coulter UniCell DxI 800 platform, the Tosoh platform gave significantly lower results (-30.2%, p=0.0024), although the two methods were very strongly correlated (R=0.991). cTnI measurements by the Tosoh analyzer were also very strongly correlated with cTnT measurements by the Roche Cobas analyzer (R=0.938), but the Tosoh measurements were approximately 10-fold higher (y=-1067 + 11.6x).
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)FrozenDiagnoses
NormalCardiovascular DiseasePlatforms
ProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinNoneBiospecimen Aliquots and Components Blood and blood products PlasmaSerumClinical chemistry/auto analyzer Specific Technology platform Beckman Coulter Uniccell DxI 800Roche Cobas e411Tosoh AIA-2000